Copyright
©The Author(s) 2025.
World J Orthop. Aug 18, 2025; 16(8): 102298
Published online Aug 18, 2025. doi: 10.5312/wjo.v16.i8.102298
Published online Aug 18, 2025. doi: 10.5312/wjo.v16.i8.102298
Table 1 American Society of Anesthesiologist grade of patients (n = 75)
| n | % | |
| Low risk | ||
| ASA 1 | 27 | 36.0 |
| ASA 2 | 45 | 60.0 |
| High risk | ||
| ASA 3 | 3 | 4.0 |
Table 2 Diagnosis of patients in males and females (n = 75)
| Diagnosis | Male (n = 55) | Female (n = 20) | Total (n = 75) | |||
| n | % | n | % | n | % | |
| Avascular necrosis | 48 | 87.27 | 11 | 55.00 | 59 | 78.67 |
| Developmental dysplasia | 0 | 0.00 | 6 | 30.00 | 6 | 8.00 |
| Ankylosing spondylitis | 3 | 5.45 | 1 | 5.00 | 4 | 5.33 |
| Osteoarthritis | 4 | 7.27 | 2 | 10.00 | 6 | 8.00 |
Table 3 History of comorbid condition in patients (n = 75)
| Comorbidity details | n | % |
| Asthma | 9 | 12.00 |
| Bronchitis | 6 | 8.00 |
| COPD | 1 | 1.33 |
| COVID | 6 | 8.00 |
| Crohn’s disease | 1 | 1.33 |
| DM | 1 | 1.33 |
| HTN | 5 | 6.67 |
| Hypothroidism | 1 | 1.33 |
| KML | 1 | 1.33 |
| Liver issues | 1 | 1.33 |
| Pancreatitis | 1 | 1.33 |
| Psoriasis | 1 | 1.33 |
| RA | 1 | 1.33 |
| Sinitis | 1 | 1.33 |
| Skin allergy | 2 | 2.67 |
| Steriod use | 1 | 1.33 |
| Total number of co-morbidities | 39 | 89.33 |
| Total number of patients with co-morbidities | 27 | 36.00 |
Table 4 Length of hospital stay and ambulatory status with percentiles (n = 75)
| n | Mean | Median | SD | Min | Max | Percentiles | |||
| 25 | 50 | 75 | |||||||
| Length of stay | 75 | 2.84 | 3.00 | 0.99 | 1 | 6 | 2 | 3 | 3 |
| Time to ambulation | 75 | 1.35 | 1.00 | 0.73 | 1 | 4 | 1 | 1 | 1 |
Table 5 Types of surgeries (n = 75)
| Types of surgery | n | % |
| Surgery type | ||
| B/L cemented THR | 9 | 12.0 |
| B/L uncemented THR | 46 | 61.3 |
| B/L hybrid hip | 20 | 26.67 |
| Surgical approach | ||
| Posterior approach | 73 | 97.3 |
| Direct acetabular approach | 1 | 1.3 |
| Post (B/L adductor tenotomy) | 1 | 1.3 |
Table 6 Blood loss and blood transfusion in patients (n = 75)
| n | Mean | Median | SD | Min | Max | % | |
| Hb (gm/dL) | |||||||
| Pre-operative | 75 | 14.20 | 14.30 | 1.95 | 7 | 18 | |
| Post-operative | 75 | 10.49 | 10.50 | 1.57 | 7 | 15 | |
| Intra-operative blood loss (mL) | 75 | 1015.33 | 1000.00 | 373.08 | 300 | 2000 | |
| Blood transfusion (unit) | |||||||
| No blood transfusion | 21 | 28.0 | |||||
| 1 | 33 | 44.0 | |||||
| 2 | 17 | 22.7 | |||||
| 3 | 4 | 5.3 | |||||
| Blood transfusion given (number of patients) | 54 | 72.0 |
- Citation: Sharma H, Verma R, Kumar L, Ali A, Khurana G, Gurnani V, Mittal S, Jajodia N. Single staged bilateral total hip replacement and its outcomes: A cross-sectional study. World J Orthop 2025; 16(8): 102298
- URL: https://www.wjgnet.com/2218-5836/full/v16/i8/102298.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i8.102298
